Abstract
Lung cancer is one of the most common cancers worldwide and has the highest mortality rate among malignant tumors in the United States (Boring et al., 1994). More than 85 % of l cancers may be attributed directly to cigarette smoking (Wynder and Hoffmann, 1994). e of the most potent carcinogens in tobacco products is the nitrosamine 4-(methyl- nitrosamino)-l-(3-pyridyl)-l-butanone (NNK) (Rivenson et al., 1988) which is formed by nitrosation of nicotine during the processing of tobacco (Burton et al., 1989) (Figure 1).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Adams, J. D., La Voie, E. J., and Hoffmann, D., 1985, On the pharmacokinetics of tobacco-specific N-nitrosamines in Fisher rats, Carcinogenesis, 6: 509–511.
Adams, J. D., LaVoie, E. J., O’Mara-Adams, K. J., Hoffmann, D., Carey, K. D., and Marshall, M. V., 1985, Pharmacokinetics of N-nitrosonornicotine and 4-methylnitrosamino-l-(3-pyridyl)-l-butanone in laboratory animals, Cancer Lett, 28: 195–201.
Boring, C. C., Squires, T. S., Tong, T., and Montgomery, S., 1994, Cancer Statistics, 1994, CA Cancer J. Clin., 44: 7–26.
Burton, H. R., Childs, G. H., Anderson, R. A., and Fleming, P. D., 1989, Changes in chemical composition of Burley tobacco during senescence and curing. 3. Tobacco specific nitrosamines, J. Agric. Food Chem., 37: 426–430.
Carmella, S. G., Akerkar, S. A., Richie, J. P., and Hecht, S. S., 1995, Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-l-(3-pyridyl)-l-butanone (NNK) in smoker’s urine, Cancer Epidemiol. Biomarkers & Prev., 4: 635–652.
Carmella, S. G., Borukhova, A., Akerkar, S. A., and Hecht, S. S., 1997, Analysis of human urine for pyridine-N-ox-ide metabolites of 4-(methylnitrosamino)-l-(3-pyridyl)-l-butanone, a tobacco-specific lung carcinogen, Cancer Epidemiol. Biomarkers Prev., 6: 113–120.
Crespi, C. L., Penman, B. W., Gelboin, H. V., and Gonzalez, F. J., 1991, A tobacco smoke-derived nitrosamine, 4-(methylnitrosamino)-l-(3-pyridyl)-l-butanone, is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P4502D6, Carcinogenesis, 12: 1197–1201.
Hecht, S. S., 1994, Metabolic activation and detoxification of tobacco-specific nitrosamines-a model for cancer prevention strategies, Drug Metab. Rev., 26: 373–390.
Hecht, S. S., Carmella, S. G., Murphy, S. E., Akerkar, S., Brunnemann, K. D., and Hoffmann, D., 1993, A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke, N. Engl. J. Med., 329: 1543–1546.
Hecht, S. S. and Hoffmann, D., 1988, Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke, Carcinogenesis, 9: 875–884.
Hecht, S. S. and Hoffmann, D., 1989, The relevance of tobacco-specific nitrosamines to human cancer, Cancer Surv., 8: 273–294.
Hecht, S. S., Trushin, N., Reid Quinn, C. A., Burak, E. S., Jones, A. B., Southers, J. L., Gombar, C. T., Carmella, S. G., Anderson, L. M., and Rice, J. M., 1993, Metabolism of the tobacco-specific nitrosamine 4-(methylni-trosamino)-l-(3-pyridyl)-l-butanone in the patas monkey: pharmacokinetics and characterization of glu-curonide metabolites, Carcinogenesis, 14: 229–236.
Hecht, S. S., Young, R., and Chen, C. B., 1980, Metabolism in the F344 rat of 4-(N-methyl-N-nitrosamino)-l-(3-pyridyl)-1-butanone, a tobacco-specific carcinogen, Cancer Res., 40: 4144–4150.
Maser, E., 1995, Xenobiotic carbonyl reduction and physiological steroid oxidoreduction-the pluripotency of several hydroxysteroid dehydrogenases, Biochem. Pharmacol, 49: 421–440.
Maser, E., 1996, llβ-Hydroxysteroid dehydrogenase acts as carbonyl reductase in microsomal phase I drug metabolism, Exp. Toxic. Pathol, 48: 266–273.
Maser, E., 1997, Stress, hormonal changes, alcohol, food constituents and drugs: factors that advance the incidence of tobacco smoke-related cancer?, Trends Pharmacol. Sci., 18: 270–275.
Maser, E., 1998, 1 lβ-Hydroxysteroid dehydrogenase responsible for carbonyl reduction of the tobacco-specific nitrosamine 4-(methylnitrosamino)-l-(3-pyridyl)-l-butanone in mouse lung microsomes, Cancer Res.,(in press)
Maser, E. and Bannenberg, G., 1994a, The purification of llβ-hydroxysteroid dehydrogenase from mouse liver microsomes, J. Steroid Biochem. Molec. Biol.,4: 257–26
Maser, E. and Bannenberg, G., 1994b, llβ-Hydroxysteroid dehydrogenase mediates reductive metabolism of xenobiotic carbonyl compounds, Biochem. Pharmacol, 47: 1805–1812.
Maser, E., Friebertshäuser, J., and Mangoura, S. A., 1994, Ontogenic pattern of carbonyl reductase activity of 1 lβ-hydroxysteroid dehydrogenase in mouse liver and kidney, Xenobiotica, 24: 109–117.
Maser, E. and Oppermann, U. C. T., 1997, Role of type-1 11 β-hydroxysteroid dehydrogenase in detoxification processes, Eur. J. Biochem., 249: 356–369.
Maser, E., Richter, E., and Friebertshauser, J., 1996, The identification of 11 beta-hydroxysteroid dehydrogenase as carbonyl reductase of the tobacco-specific nitrosamine 4-(methylnitrosamino)-l-(3-pyridyl)-l-butanone, Eur J. Biochem., 238: 484–89.
Meger, M., Meger-Kossien, I., Dietrich, M., Tricker, A. R., Scherer, G., and Adlkofer, F., 1996, Metabolites of 4-(N-methylnitrosamino)-l-(3-pyridyl)-l-butanone in urine of smokers, Eur. J. Cancer Prev., 5 (Suppl. l): 121–12
Murphy, S. E., Palomino, A., Hecht, S. S., and Hoffmann, D., 1990, Dose-response study of DNA and hemoglobin adduct formation by 4-(methylnitrosamino)-l-(3-pyridyl)-l-butanone in F344 rats, Cancer Res., 50: 5446–5452.
Oppermann, U. C. T., Netter, K. J., and Maser, E., 1995, Cloning and primary structure of murine 11 β-hydroxysteroid dehydrogenase/microsomal carbonyl reductase, Eur. J. Biochem., 227: 202–208.
Rekka, E. A., Soldan, M., Belai, I., Netter, K. J., and Maser, E., 1996, Biotransformation and detoxification of in-secticidal metyrapone analogues by carbonyl reduction in the human liver, Xenobiotica, 26: 1221–1229.
Riddle, M. C. and McDaniel, P. A., 1993, Acute reduction of renal 11 beta-hydroxysteroid dehydrogenase activity by several antinatriuretic stimuli, Metabolism, 42: 1370–1374.
Rivenson, A., Hoffmann, D., Prokopczyk, B., Amin, S., and Hecht, S. S., 1988, Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines, Cancer Res., 48: 6912–6917.
Seckl, J. R., 1993, 11 β-Hydroxysteroid dehydrogenase isoforms and their implications for blood pressure regulation, Eur. J. Clin. Invest., 23: 589–601.
Valentino, R., Tommaselli, A. P., Savastano, S., Stewart, P. M., Ghiggi, M. R., Galletti, F., Mariniello, P., Lombardi, G., and Edwards, C. R., 1995, Alcohol inhibits 11-beta-hydroxysteroid dehydrogenase activity in rat kidney and liver, Horm. Res., 43: 176–180.
Wynder, E. L. and Hoffmann, D., 1994, Smoking and lung cancer: scientific challenges and opportunities, Cancer Res., 54: 5284–5295.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Maser, E. (1999). The Protective Role of 11β-Hydroxysteroid Dehydrogenase/Carbonyl Reductase Against Tobacco-Smoke Related Lung Cancer. In: Weiner, H., Maser, E., Crabb, D.W., Lindahl, R. (eds) Enzymology and Molecular Biology of Carbonyl Metabolism 7. Advances in Experimental Medicine and Biology, vol 463. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4735-8_47
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4735-8_47
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7146-5
Online ISBN: 978-1-4615-4735-8
eBook Packages: Springer Book Archive